Phase I Study of Weekly LOC-paclitaxel Injection

Trial Profile

Phase I Study of Weekly LOC-paclitaxel Injection

Phase of Trial: Phase I

Latest Information Update: 06 Jun 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Malignant melanoma; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 May 2016 Status changed from completed to discontinued.
    • 25 Feb 2016 Status changed from active, no longer recruiting to completed as reported by
    • 15 Jul 2014 According to the record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top